# IndeCon, Inc. – FDA Inspection, Nov 22, 2016

Source: https://www.keypedia.com/records/fda_inspections/indecon-inc/81c813a0-59c5-4f9b-a601-bdf071cef1cf
Source feed: FDA_Inspections

> FDA inspection 998132 of IndeCon, Inc., November 22, 2016. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 1271. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 998132
- Company Name: IndeCon, Inc.
- Inspection Date: 2016-11-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1256367 - 2024-12-12](https://www.keypedia.com/records/fda_inspections/indecon-inc/d75d58fc-1bd4-44ad-bbe6-a64f8feebaba)
- [FDA Inspection 880573 - 2014-05-29](https://www.keypedia.com/records/fda_inspections/indecon-inc/d7e6e7b4-204c-4ccf-939f-20039f8ce5e7)

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/indecon-inc/4e69c625-7949-4a8f-8792-1c94387f1de7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
